Posted April 27, 2016
On 25 April, PR Newswire carried an announcement by a law firm that is investigating the biotech firm Intrexon on behalf of investors over potential violations of US securities law. The law firm cites allegations in a new report on Intrexon’s performance and prospects from a company called Spotlight Research. The law firm invites people who have purchased shares or have information on Intrexon’s dealings to get in contact. Two other law firms have also launched investigations. Read more.